BrightBid Group AB (publ) (PERP-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.045x

Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has a cash flow conversion efficiency ratio of -0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.39 Million ≈ $-149.91K USD) by net assets (Skr30.77 Million ≈ $3.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BrightBid Group AB (publ) net asset quality index to measure how much of total assets are equity-financed.

BrightBid Group AB (publ) - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BrightBid Group AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BrightBid Group AB (publ) earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

BrightBid Group AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BrightBid Group AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Weaccess Group SA
PA:MLWEA
0.230x
Madhav Marbles and Granites Limited
NSE:MADHAV
-0.005x
PreveCeutical Medical Inc
F:18H
0.070x
Agereh Technologies Inc
V:AUTO
0.039x
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
-0.123x
Zephyr Minerals Ltd
V:ZFR
0.006x
BPH Global Ltd
AU:BP8
0.413x
Caledonia Mining Corporation Plc
LSE:CMCL
0.050x

Annual Cash Flow Conversion Efficiency for BrightBid Group AB (publ) (2012–2025)

The table below shows the annual cash flow conversion efficiency of BrightBid Group AB (publ) from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see BrightBid Group AB (publ) market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr30.77 Million
≈ $3.31 Million
Skr-5.46 Million
≈ $-587.91K
-0.178x +72.55%
2024-12-31 Skr10.87 Million
≈ $1.17 Million
Skr-7.03 Million
≈ $-756.25K
-0.647x +68.19%
2023-12-31 Skr8.07 Million
≈ $868.57K
Skr-16.41 Million
≈ $-1.77 Million
-2.033x -48.69%
2022-12-31 Skr14.03 Million
≈ $1.51 Million
Skr-19.19 Million
≈ $-2.06 Million
-1.368x -85.77%
2021-12-31 Skr20.83 Million
≈ $2.24 Million
Skr-15.34 Million
≈ $-1.65 Million
-0.736x -7.92%
2020-12-31 Skr14.97 Million
≈ $1.61 Million
Skr-10.21 Million
≈ $-1.10 Million
-0.682x +16.19%
2019-12-31 Skr17.03 Million
≈ $1.83 Million
Skr-13.86 Million
≈ $-1.49 Million
-0.814x -1.25%
2018-12-31 Skr13.72 Million
≈ $1.48 Million
Skr-11.03 Million
≈ $-1.19 Million
-0.804x +3.28%
2017-12-31 Skr11.24 Million
≈ $1.21 Million
Skr-9.34 Million
≈ $-1.01 Million
-0.831x +88.04%
2016-12-31 Skr1.32 Million
≈ $141.82K
Skr-9.16 Million
≈ $-985.37K
-6.948x -555.55%
2015-12-31 Skr5.53 Million
≈ $595.30K
Skr-5.86 Million
≈ $-630.95K
-1.060x -485.35%
2014-12-31 Skr6.12 Million
≈ $659.05K
Skr-1.11 Million
≈ $-119.34K
-0.181x +12.07%
2013-12-31 Skr4.21 Million
≈ $453.06K
Skr-867.00K
≈ $-93.30K
-0.206x -263.26%
2012-12-31 Skr4.06 Million
≈ $436.60K
Skr-230.00K
≈ $-24.75K
-0.057x --

About BrightBid Group AB (publ)

ST:PERP-B USA Medical Devices
Market Cap
$3.33 Million
Skr30.98 Million SEK
Market Cap Rank
#29307 Global
#5920 in USA
Share Price
Skr3.62
Change (1 day)
+17.92%
52-Week Range
Skr3.03 - Skr5.56
All Time High
Skr5.56
About

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the t… Read more